MedTrace Logo

Oxytocin Effects on Cardiac Electrophysiology

NCT01780337 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2016-07-21

Study results available
· View outcomes & findings →

Summary

In this pilot study the investigators will perform a double-blind randomized trial of intranasal oxytocin on measures of cardiac refractoriness, among individuals who are undergoing clinically indicated catheter ablation procedures for paroxysmal atrial fibrillation. The investigators seek to enroll 20 patients for this study, for the purpose of estimating effect sizes for a larger future study.

Conditions

  • Cardiac Arrhythmia

Interventions

DRUG

Oxytocin

Intranasal dose of 20 IU oxytocin

OTHER

Saline

Intranasal dose of saline

Sponsors & Collaborators

  • William Whang

    lead OTHER

Principal Investigators

  • William Whang, MD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01780337 on ClinicalTrials.gov